QHSLab, Inc. Files 8-K for Disclosure and Exhibits

Ticker: USAQ · Form: 8-K · Filed: Jul 8, 2025 · CIK: 856984

Sentiment: neutral

Topics: disclosure, filing, exhibits

TL;DR

QHSLab filed an 8-K on 7/8/25 for disclosures and exhibits - check for material updates.

AI Summary

On July 8, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or material events beyond these procedural disclosures were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates that QHSLab, Inc. is providing updates or disclosures required by the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose any new material financial information or significant corporate events that would inherently increase risk.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided excerpt of the 8-K filing does not specify the content of the Regulation FD Disclosure, only that it is being filed.

What financial statements and exhibits are being filed with this 8-K?

The excerpt states that Financial Statements and Exhibits are being filed, but does not list their specific contents.

When was QHSLab, Inc. incorporated in Nevada?

The filing indicates the state of incorporation is Nevada, but does not provide the incorporation date.

What is the business phone number for QHSLab, Inc.?

The business phone number listed for QHSLab, Inc. is (929) 379-6503.

Has QHSLab, Inc. had previous names?

Yes, QHSLab, Inc. was formerly known as USA EQUITIES CORP. (name change 20151119), USA EQUITY CORP. (name change 20151116), and AMERICAN BIOGENETIC SCIENCES INC (name change 19940426).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding QHSLab, Inc. (USAQ).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing